Global Emergency Contraceptives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 91
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Emergency Contraceptives market size was valued at USD 584.4 million in 2023 and is forecast to a readjusted size of USD 942.3 million by 2030 with a CAGR of 7.1% during review period.
The emergency contraceptives market refers to the industry involved in the production, distribution, and sale of medications and products used for emergency contraception. Emergency contraceptives, also known as "morning-after pills," are designed to prevent pregnancy after unprotected intercourse or contraceptive failure.
The emergency contraceptives market is a segment within the broader contraceptive industry. It focuses on providing women with safe and effective options for emergency contraception when regular contraceptive methods have failed, were not used, or in cases of sexual assault.
The emergency contraceptives market is influenced by factors such as changing societal norms, increasing awareness of contraception options, rising demand for reproductive healthcare services, and initiatives to reduce unintended pregnancies. Additionally, the market is driven by advancements in emergency contraceptive formulations and the expansion of distribution channels.
The Global Info Research report includes an overview of the development of the Emergency Contraceptives industry chain, the market status of Hospital pharmacies (Combined Estrogen and Progestin Pills, Progestin-Only (As Levonorgestrel) Pills), Retail pharmacies (Combined Estrogen and Progestin Pills, Progestin-Only (As Levonorgestrel) Pills), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Emergency Contraceptives.
Regionally, the report analyzes the Emergency Contraceptives markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Emergency Contraceptives market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Emergency Contraceptives market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Emergency Contraceptives industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Combined Estrogen and Progestin Pills, Progestin-Only (As Levonorgestrel) Pills).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Emergency Contraceptives market.
Regional Analysis: The report involves examining the Emergency Contraceptives market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Emergency Contraceptives market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Emergency Contraceptives:
Company Analysis: Report covers individual Emergency Contraceptives manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Emergency Contraceptives This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital pharmacies, Retail pharmacies).
Technology Analysis: Report covers specific technologies relevant to Emergency Contraceptives. It assesses the current state, advancements, and potential future developments in Emergency Contraceptives areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Emergency Contraceptives market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Emergency Contraceptives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Combined Estrogen and Progestin Pills
Progestin-Only (As Levonorgestrel) Pills
Antiprogestin (As Mifepristone) Pills
Ulipristal Acetate Pills
Market segment by Application
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
Major players covered
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Emergency Contraceptives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Emergency Contraceptives, with price, sales, revenue and global market share of Emergency Contraceptives from 2019 to 2024.
Chapter 3, the Emergency Contraceptives competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Emergency Contraceptives breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Emergency Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Emergency Contraceptives.
Chapter 14 and 15, to describe Emergency Contraceptives sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Emergency Contraceptives
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Emergency Contraceptives Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Combined Estrogen and Progestin Pills
1.3.3 Progestin-Only (As Levonorgestrel) Pills
1.3.4 Antiprogestin (As Mifepristone) Pills
1.3.5 Ulipristal Acetate Pills
1.4 Market Analysis by Application
1.4.1 Overview: Global Emergency Contraceptives Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital pharmacies
1.4.3 Retail pharmacies
1.4.4 Online pharmacies
1.4.5 Others
1.5 Global Emergency Contraceptives Market Size & Forecast
1.5.1 Global Emergency Contraceptives Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Emergency Contraceptives Sales Quantity (2019-2030)
1.5.3 Global Emergency Contraceptives Average Price (2019-2030)
2.1 Genetics
2.1.1 Genetics Details
2.1.2 Genetics Major Business
2.1.3 Genetics Emergency Contraceptives Product and Services
2.1.4 Genetics Emergency Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Genetics Recent Developments/Updates
2.2 Teva Pharmaceutical
2.2.1 Teva Pharmaceutical Details
2.2.2 Teva Pharmaceutical Major Business
2.2.3 Teva Pharmaceutical Emergency Contraceptives Product and Services
2.2.4 Teva Pharmaceutical Emergency Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Teva Pharmaceutical Recent Developments/Updates
2.3 Uniprix
2.3.1 Uniprix Details
2.3.2 Uniprix Major Business
2.3.3 Uniprix Emergency Contraceptives Product and Services
2.3.4 Uniprix Emergency Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Uniprix Recent Developments/Updates
2.4 Gavis Pharmaceuticals
2.4.1 Gavis Pharmaceuticals Details
2.4.2 Gavis Pharmaceuticals Major Business
2.4.3 Gavis Pharmaceuticals Emergency Contraceptives Product and Services
2.4.4 Gavis Pharmaceuticals Emergency Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Gavis Pharmaceuticals Recent Developments/Updates
2.5 HRA Pharma
2.5.1 HRA Pharma Details
2.5.2 HRA Pharma Major Business
2.5.3 HRA Pharma Emergency Contraceptives Product and Services
2.5.4 HRA Pharma Emergency Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 HRA Pharma Recent Developments/Updates
2.6 Mankind Pharma
2.6.1 Mankind Pharma Details
2.6.2 Mankind Pharma Major Business
2.6.3 Mankind Pharma Emergency Contraceptives Product and Services
2.6.4 Mankind Pharma Emergency Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mankind Pharma Recent Developments/Updates
3.1 Global Emergency Contraceptives Sales Quantity by Manufacturer (2019-2024)
3.2 Global Emergency Contraceptives Revenue by Manufacturer (2019-2024)
3.3 Global Emergency Contraceptives Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Emergency Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Emergency Contraceptives Manufacturer Market Share in 2023
3.4.2 Top 6 Emergency Contraceptives Manufacturer Market Share in 2023
3.5 Emergency Contraceptives Market: Overall Company Footprint Analysis
3.5.1 Emergency Contraceptives Market: Region Footprint
3.5.2 Emergency Contraceptives Market: Company Product Type Footprint
3.5.3 Emergency Contraceptives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Emergency Contraceptives Market Size by Region
4.1.1 Global Emergency Contraceptives Sales Quantity by Region (2019-2030)
4.1.2 Global Emergency Contraceptives Consumption Value by Region (2019-2030)
4.1.3 Global Emergency Contraceptives Average Price by Region (2019-2030)
4.2 North America Emergency Contraceptives Consumption Value (2019-2030)
4.3 Europe Emergency Contraceptives Consumption Value (2019-2030)
4.4 Asia-Pacific Emergency Contraceptives Consumption Value (2019-2030)
4.5 South America Emergency Contraceptives Consumption Value (2019-2030)
4.6 Middle East and Africa Emergency Contraceptives Consumption Value (2019-2030)
5.1 Global Emergency Contraceptives Sales Quantity by Type (2019-2030)
5.2 Global Emergency Contraceptives Consumption Value by Type (2019-2030)
5.3 Global Emergency Contraceptives Average Price by Type (2019-2030)
6.1 Global Emergency Contraceptives Sales Quantity by Application (2019-2030)
6.2 Global Emergency Contraceptives Consumption Value by Application (2019-2030)
6.3 Global Emergency Contraceptives Average Price by Application (2019-2030)
7.1 North America Emergency Contraceptives Sales Quantity by Type (2019-2030)
7.2 North America Emergency Contraceptives Sales Quantity by Application (2019-2030)
7.3 North America Emergency Contraceptives Market Size by Country
7.3.1 North America Emergency Contraceptives Sales Quantity by Country (2019-2030)
7.3.2 North America Emergency Contraceptives Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Emergency Contraceptives Sales Quantity by Type (2019-2030)
8.2 Europe Emergency Contraceptives Sales Quantity by Application (2019-2030)
8.3 Europe Emergency Contraceptives Market Size by Country
8.3.1 Europe Emergency Contraceptives Sales Quantity by Country (2019-2030)
8.3.2 Europe Emergency Contraceptives Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Emergency Contraceptives Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Emergency Contraceptives Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Emergency Contraceptives Market Size by Region
9.3.1 Asia-Pacific Emergency Contraceptives Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Emergency Contraceptives Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Emergency Contraceptives Sales Quantity by Type (2019-2030)
10.2 South America Emergency Contraceptives Sales Quantity by Application (2019-2030)
10.3 South America Emergency Contraceptives Market Size by Country
10.3.1 South America Emergency Contraceptives Sales Quantity by Country (2019-2030)
10.3.2 South America Emergency Contraceptives Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Emergency Contraceptives Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Emergency Contraceptives Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Emergency Contraceptives Market Size by Country
11.3.1 Middle East & Africa Emergency Contraceptives Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Emergency Contraceptives Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Emergency Contraceptives Market Drivers
12.2 Emergency Contraceptives Market Restraints
12.3 Emergency Contraceptives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Emergency Contraceptives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Emergency Contraceptives
13.3 Emergency Contraceptives Production Process
13.4 Emergency Contraceptives Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Emergency Contraceptives Typical Distributors
14.3 Emergency Contraceptives Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Emergency Contraceptives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Emergency Contraceptives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Genetics Basic Information, Manufacturing Base and Competitors
Table 4. Genetics Major Business
Table 5. Genetics Emergency Contraceptives Product and Services
Table 6. Genetics Emergency Contraceptives Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Genetics Recent Developments/Updates
Table 8. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Teva Pharmaceutical Major Business
Table 10. Teva Pharmaceutical Emergency Contraceptives Product and Services
Table 11. Teva Pharmaceutical Emergency Contraceptives Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Teva Pharmaceutical Recent Developments/Updates
Table 13. Uniprix Basic Information, Manufacturing Base and Competitors
Table 14. Uniprix Major Business
Table 15. Uniprix Emergency Contraceptives Product and Services
Table 16. Uniprix Emergency Contraceptives Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Uniprix Recent Developments/Updates
Table 18. Gavis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Gavis Pharmaceuticals Major Business
Table 20. Gavis Pharmaceuticals Emergency Contraceptives Product and Services
Table 21. Gavis Pharmaceuticals Emergency Contraceptives Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Gavis Pharmaceuticals Recent Developments/Updates
Table 23. HRA Pharma Basic Information, Manufacturing Base and Competitors
Table 24. HRA Pharma Major Business
Table 25. HRA Pharma Emergency Contraceptives Product and Services
Table 26. HRA Pharma Emergency Contraceptives Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. HRA Pharma Recent Developments/Updates
Table 28. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Mankind Pharma Major Business
Table 30. Mankind Pharma Emergency Contraceptives Product and Services
Table 31. Mankind Pharma Emergency Contraceptives Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Mankind Pharma Recent Developments/Updates
Table 33. Global Emergency Contraceptives Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Emergency Contraceptives Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Emergency Contraceptives Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Emergency Contraceptives, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Emergency Contraceptives Production Site of Key Manufacturer
Table 38. Emergency Contraceptives Market: Company Product Type Footprint
Table 39. Emergency Contraceptives Market: Company Product Application Footprint
Table 40. Emergency Contraceptives New Market Entrants and Barriers to Market Entry
Table 41. Emergency Contraceptives Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Emergency Contraceptives Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Emergency Contraceptives Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Emergency Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Emergency Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Emergency Contraceptives Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Emergency Contraceptives Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Emergency Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Emergency Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Emergency Contraceptives Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Emergency Contraceptives Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Emergency Contraceptives Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Emergency Contraceptives Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Emergency Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Emergency Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Emergency Contraceptives Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Emergency Contraceptives Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Emergency Contraceptives Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Emergency Contraceptives Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Emergency Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Emergency Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Emergency Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Emergency Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Emergency Contraceptives Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Emergency Contraceptives Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Emergency Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Emergency Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Emergency Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Emergency Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Emergency Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Emergency Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Emergency Contraceptives Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Emergency Contraceptives Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Emergency Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Emergency Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Emergency Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Emergency Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Emergency Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Emergency Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Emergency Contraceptives Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Emergency Contraceptives Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Emergency Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Emergency Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Emergency Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Emergency Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Emergency Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Emergency Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Emergency Contraceptives Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Emergency Contraceptives Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Emergency Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Emergency Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Emergency Contraceptives Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Emergency Contraceptives Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Emergency Contraceptives Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Emergency Contraceptives Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Emergency Contraceptives Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Emergency Contraceptives Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Emergency Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Emergency Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Emergency Contraceptives Raw Material
Table 101. Key Manufacturers of Emergency Contraceptives Raw Materials
Table 102. Emergency Contraceptives Typical Distributors
Table 103. Emergency Contraceptives Typical Customers
List of Figures
Figure 1. Emergency Contraceptives Picture
Figure 2. Global Emergency Contraceptives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Emergency Contraceptives Consumption Value Market Share by Type in 2023
Figure 4. Combined Estrogen and Progestin Pills Examples
Figure 5. Progestin-Only (As Levonorgestrel) Pills Examples
Figure 6. Antiprogestin (As Mifepristone) Pills Examples
Figure 7. Ulipristal Acetate Pills Examples
Figure 8. Global Emergency Contraceptives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Emergency Contraceptives Consumption Value Market Share by Application in 2023
Figure 10. Hospital pharmacies Examples
Figure 11. Retail pharmacies Examples
Figure 12. Online pharmacies Examples
Figure 13. Others Examples
Figure 14. Global Emergency Contraceptives Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Emergency Contraceptives Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Emergency Contraceptives Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Emergency Contraceptives Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Emergency Contraceptives Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Emergency Contraceptives Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Emergency Contraceptives by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Emergency Contraceptives Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Emergency Contraceptives Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Emergency Contraceptives Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Emergency Contraceptives Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Emergency Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Emergency Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Emergency Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Emergency Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Emergency Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Emergency Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Emergency Contraceptives Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Emergency Contraceptives Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Emergency Contraceptives Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Emergency Contraceptives Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Emergency Contraceptives Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Emergency Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Emergency Contraceptives Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Emergency Contraceptives Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Emergency Contraceptives Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Emergency Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Emergency Contraceptives Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Emergency Contraceptives Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Emergency Contraceptives Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Emergency Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Emergency Contraceptives Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Emergency Contraceptives Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Emergency Contraceptives Consumption Value Market Share by Region (2019-2030)
Figure 56. China Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Emergency Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Emergency Contraceptives Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Emergency Contraceptives Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Emergency Contraceptives Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Emergency Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Emergency Contraceptives Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Emergency Contraceptives Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Emergency Contraceptives Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Emergency Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Emergency Contraceptives Market Drivers
Figure 77. Emergency Contraceptives Market Restraints
Figure 78. Emergency Contraceptives Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Emergency Contraceptives in 2023
Figure 81. Manufacturing Process Analysis of Emergency Contraceptives
Figure 82. Emergency Contraceptives Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Genetics Teva Pharmaceutical Uniprix Gavis Pharmaceuticals HRA Pharma Mankind Pharma
Related Reports
13 Feb 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
